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Otitis externa is one of the most common diseases in dogs. It is associated with bacteria
and yeast, which are regarded as secondary causes. Cerumen is a biological substance
playing an important role in the protection of ear skin. The involvement of cerumen
in immune defense is poorly understood. MicroRNAs can modulate the host immune
response and can provide promising biomarkers for several inflammatory and infectious
disorder diagnosis. The aims of this study were to profile the cerumen miRNA signature
associated with otitis externa in dogs, integrate miRNAs to their target genes related
to immune functions, and investigate their potential use as biomarkers. Cerumen was
collected from healthy and otitis affected dogs and the expression of miRNAs was
profiled by Next Generation Sequencing; the validation of the altered miRNAs was
performed using RT-qPCR. The potential ability of miRNAs to modulate immune-related
genes was investigated using bioinformatics tools. The results pointed out that 32
miRNAs, of which 14 were up- and 18 down-regulated, were differentially expressed in
healthy vs. otitis-affected dogs. These results were verified by RT-qPCR. To assess the
diagnostic value of miRNAs, ROC analysis was carried out, highlighting that 4 miRNAs
are potential biomarkers to discriminate otitis-affected dogs. Bioinformatics showed
that cerumen miRNAs may be involved in the modulation of host immune response.
In conclusion, we have demonstrated for the first time that miRNAs can be efficiently
extracted and quantified from cerumen, that their profile changes between healthy and
otitis affected dogs, and that they may serve as potential biomarkers. Further studies
are necessary to confirm their diagnostic value and to investigate their interaction with
immune-related genes.
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INTRODUCTION
Otitis externa is defined as the inflammation of the external ear
canal and represents one of the most prevalent skin disorders
in dogs (1–4). The causes of otitis externa can be divided into
primary and secondary (5, 6). Primary causes of otitis include
inflammatory conditions, such as autoimmune or immune-
mediated diseases, keratinization and glandular disorders, and
ectoparasites. Onset of secondary causes such as bacterial
and Malassezia spp. infections is generally associated by the
emergence of primary diseases such as canine atopic dermatitis
or combined with several predisposing factors (7). The host
immune response to microorganisms in the external ear canal
likely plays a pivotal role, but few data are available in dogs,
except for studies on the immune reaction against Malassezia
(8–10). Cerumen, or earwax, is a biological substance composed
of lipids, proteins, amino acids, and carbohydrates produced by
the combination of the excretions of ceruminous and sebaceous
glands in the auditory canal of the external ear of mammalians.
Cerumen is believed to protect the epithelial lining of the ear
canal against pathogens. Besides its importance as a physical
barrier, the involvement of cerumen in other functions, including
specific immune defense, remains largely unexplored. Cerumen
is supposedly involved in antimicrobial defense as demonstrated
by the presence of lysozyme and immunoglobulins (11), as
well as of additional proteins with antimicrobial functions,
as recently shown by proteomics (12). In human cerumen,
proteins belonging to β-defensin families were also detected (13),
suggesting a possible role in the local innate immune response.
In addition to its biological function, cerumen has gained
interest in the clinical setting as a potential source of
biomarkers (14). Cerumen composition indeed reflects the
pathophysiological status of the patient, containing lipids,
proteins, and metabolites derived from blood (14). Although
the amount and the variation of texture and color of cerumen
during ear diseases have been accurately described in dogs (15),
the active protective role of cerumen in the development of
immunity during otitis externa is yet to be determined.
MicroRNAs (miRNAs) are short (∼22 nucleotides), single-
stranded non-coding RNAs that modulate gene expression
by binding to complementary target mRNA. MiRNAs down-
regulate gene expression by silencing or degrading their mRNA
target (16). Extensive research over the last years demonstrated
that miRNAs fulfill a fundamental role in pathogen recognition
and inflammatory responses (17). The profile of miRNAs is
tissue-dependent and relative stable during several disorders and
pathological alterations. Therefore, besides their importance as
regulators of immune defenses and inflammation, miRNAs also
provide promising targets and biomarkers for molecular-based
diagnostics and therapies in both humans (18) and animals (19–
21). Changes in miRNAs expression pattern have been observed
in association with skin diseases (22) and in otitis media, where
they were located in middle ear fluid exosomes (23, 24).
Since no information on miRNAs derangements in canine
otitis externa is available, and that cerumen might provide
a source of biomarkers, the present study aimed to assess
miRNAs expression profiles in the cerumen of dogs affected
by otitis externa. This study tested the hypothesis that (a)
cerumen microRNA could be differentially abundant between
healthy and otitis affected dogs; (b) cerumen microRNA could
provide a source of biomarkers to discriminate between healthy
and otitis-affected dogs, and (c) cerumen could be a source
of microRNAs involved in immune reaction, and as such
participates to the regulation of ear innate immunity. A next-
generation sequencing pilot study was carried out to identify a list
of potential differentially expressed (DE)-miRNAs extracted from
cerumen. Results were validated and quantified by RT-qPCR, and
functional enrichment analysis of target genes and functional
interaction network analysis was finally carried out to identify
pathways potentially affected by DE-miRNAs.
MATERIALS AND METHODS
Subjects and Sample Collection
The study was prospective, randomized, and blinded. Twenty
client-owned dogs, of which 16 with bilateral and 4 with
unilateral bacterial otitis externa, were included. Written
informed consent was secured from dog owners prior to
enrolment. Diagnosis of otitis externa was based on history,
clinical signs such as head shaking, pruritus, local pain, otorrhea,
erythema, or swelling of at least one ear canal, visible debris
and discharge in the ear canal upon otoscopic examination,
and cytological confirmation of bacterial overgrowth and/or
bacterial infection by microscopic examination of the exudate.
To collect the ear exudate, the external ear canal of the right
and left ear was swabbed and the non-sterile cotton-tipped
swabs obtained were streaked onto two glass slides, which were
then heat-fixed and stained with a modified Wright’s stain
(Quick Panoptic Kit; Pokler Italia). At least 10 fields per slide
were examined under optical microscopy and a number of
bacteria ≥25 per high power microscopy field (400×), with or
without bacterial phagocytosis by neutrophil granulocytes, were
considered positive (infection) as previously described (25). Dogs
with any topical or ongoing treatments for otitis externa were
excluded. In the control group, 28 dogs deemed healthy based on
history, physical, and otoscopic examination and on the absence
of neutrophil granulocytes, bacteria <25 and yeast <5 per high
power microscopical field (400x) on ear cytology (25) were
included. Supplementary Table 1 summarizes the characteristics
of dogs.
After inclusion, the skin of each vertical ear canal was sampled
by rubbing (I) a tubed sterile dry swabTM rayon [ref MW1028;
MWE Co (Bath) LTD—England] for small RNA extraction; (II) a
Transystem AMIES w/o charcoal plastic applicator rayon tipped
swab (Copan Italia SPA—Brescia—Italy) for microbiological test;
and (III) a non-sterile cotton-tipped swab for cytology for 10 s.
Microbiological Analysis
Microbiological analyses were performed as previously reported
(26). Each swab was plated on Blood Agar plates with 5%
sheep blood (Thermo Fisher Scientific), Mannitol Salt Agar
(Thermo Fisher Scientific), and Mac Conkey agar (Thermo
Fisher Scientific); the plates were aerobically incubated at 37◦C
for 24–48 h.
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The same samples were plated on Sabouraud’s dextrose agar
with chloramphenicol and incubated at 30◦C for 7 days and were
used to identify the fungal flora.
The isolated bacteria were identified according to standard
laboratory procedures (morphology, Gram staining, catalase,
oxidase, etc.) and subjected to biochemical identification using
the API system (bioMèerieux SA, Marcy L’Etoile, France). The
species identification by miniaturized biochemical tests was
accepted when the probability was>90%.
Cytology
The ear swabs were air-dried and stained with May-Grünwald
Giemsa. The following parameters were evaluated at the
microscope: cellularity, presence of epithelial cells, inflammatory
cells, bacteria, and Malassezia spp. A semi-quantitative scoring
system to evaluate all the parameters was designed. A five-
point scale scoring was proposed as follows: 0, absent; 1,
very rare presence; 2, mild presence (scarce number in some
microscopic fields); 3, moderate presence (variable number in
almost all microscopic fields); or 4, good presence (good number
in all microscopic fields). When bacteria were present, their
morphology was recorded.
Small RNA Extraction and Sequencing
Total RNA was extracted using miRNeasy Serum/Plasma
Kit (Qiagen, Cat. No 217184) following the manufacturer’s
instruction. The RNA quality and quantity were verified
according to MIQE guidelines (27). For all samples, RNA
concentration was quantified by Qubit R© 2.0 Fluorometer with
Qubit R© microRNA Assay Kit (Invitrogen, Cat. No. Q32880).
A pilot sequencing was performed on 3 healthy
(Supplementary Table 1, no. 15 right, 19 right, and 20 right) and
3 otitis-affected samples (Supplementary Table 1, no. 32 left, 35
left, and 41 right). Small RNA transcripts were converted into
barcoded cDNA libraries. Library preparation was performed
as previously reported (28) using the NEBNext Multiplex small
RNA Library Prep Set (Cat. No. NEB#E7560) for Illumina and
run on the NextSeq500 (Illumina Inc., USA).
Computational Analyses
The output of NextSeq500 Illumina sequencer was demultiplexed
using bcl2fastq Illumina software embedded in docker4seq
package (29). miRNA expression quantification was performed
using the workflow previously described (30), using the
implementation as previously described (31). In brief, after
adapter trimming with cutadapt (32), sequences were mapped
using SHRIMP (33) to Canis familiaris precursors miRNAs
available in miRBase 22.0—March 2018 (http://www.mirbase.
org/). Counts table and cpm tables were used.
Validation by RT-qPCR
Total RNA was extracted from all samples included in the
study using miRNeasy Serum/Plasma Kit (Qiagen, Cat. No.
217184). One ml of Qiazol (Qiagen) was added and, after
incubation at room temperature for 5min, 3.75 µl (25 fmol
final concentration) of the exogenous synthetic spike-in control
Caenorhabditis elegans miRNA cel-miR-39 (Qiagen, Cat. No.
219610) was spiked into samples. The reverse transcription was
performed using the TaqMan Advanced miRNA cDNA Synthesis
Kit (Applied Biosystems, Cat. No. A28007) as per manufacturer’s
instruction. The qPCR experiments were designed following
MIQE guidelines (27). The small RNA TaqMan assays were
performed according to the manufacturer’s instructions using
the selected primer/probe assays (ThermoFisher Scientific),
including: cel-miR-39-3p (assay ID 478293_mir); cfa-miR-
21-5p (assay ID rno481342_mir); cfa-miR-26a-5p (assay ID
mmu481013_mir); cfa-miR-27b-3p (assay ID rno478270_mir);
cfa-miR-320a-3p (assay ID 478594_mir); cfa-miR-342-3p (assay
ID 478043_mir); cfa-miR-146a-5p (assay ID 478399_mir); cfa-
miR-378a-3p (assay ID 478349_mir); cfa-miR-375-3p (assay ID
mmu481141_mir); cfa-miR-423-5p (assay ID mmu481834_mir);
miR-125b (assay ID rno480907_mir); and miR-199 (custom-
designed). miRNAs were selected among those with the highest
read counts. Quantitative reactions were performed in duplicate
in scaled down (15 µl) reaction volumes using the TaqMan
Fast Advanced Master Mix (Applied Biosystems, Cat. No.
4444558) on CFX96 Real-Time PCR detection system (BioRad
Laboratories). The standard cycling program was 50◦C for
2min, 95◦C for 3min, and 40 cycles of 95◦C for 10 s and
60◦C for 30 s. Endogenous control for qPCR normalization
was identified adapting the pipeline developed by Eisenberg
and Levanon (34). Briefly, reference miRNAs were selected
considering the individual raw count and with at least 50 reads
for each sample; a standard error of the log2 fold change
value <0.75 and a log2 fold change ranging between −0.074
and 0.46. Three reference miRNAs (cfa-miR-21, cfa-miR-26a,
and cfa-miR27b) have been selected. No-RT controls and no-
template controls were performed. The geometric mean of
reference miRNA abundance was used for normalization. The
relative quantification of target miRNAs was carried out after
normalization of the sample using the geometric mean of
reference miRNAs.
miRNA Target Prioritization
The target genes of DE-miRNAs were predicted using MiRWalk
3.0 (35), which includes 3 miRNA-target prediction programs
[miRDB (36), miRTarBase (37), and Targetscan (38)]. The
analysis was performed targeting the entire gene sequence
(including 5
′
UTR, CDS, and 3′UTR). The list of target
genes predicted by the three tools was included in further
analysis and functional mRNA enrichment was performed using
DAVID (Database for Annotation, Visualization and Integrated
Discovery) bioinformatic resource (39, 40) and biological
pathways in the KEGG (Kyoto Encyclopedia of Genes and
Genomes) (41) were examined for enrichment. To visualize
the interaction between immune-related genes and up- and
down-regulated miRNAs, miRNet (42) software was employed to
construct the miRNA-hub gene networks.
Computational and Statistical Analysis
Raw reads quality-check, adapter clipping, and mapping were
performed as previously reported (30). After reads mapping,
a matrix of integer values was created. The value in the i-th
row and the j-th column of the matrix reported how many
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reads have been unambiguously assigned to mature miRNA i in
the sample j. The unwanted variation present in the data was
estimated using the functions implemented in the SVA package
(43). The differential expression analysis was run using DESeq2
(44), setting a thresholds adjusted p < 0.1 and |log2FC| >1.
The differential expressed miRNAs (DE-miRNAs) were those
associated with adjusted False Discovery Rate (FDR) ≤0.05 and
the mean read count ≥300.
Statistical analysis was carried out using XLStat for Windows
(Addinsoft, New York, U.S.A.), IBM SPSS Statistics 25 software
(IBM Corp., 2017) and MedCalc 14.0 (MedCalc Software bvba,
Ostend, Belgium). Statistical significance was accepted at p <
0.05. Data were tested for normality and homogeneity of variance
using the Kolmogorov-Smirnov and Levene tests, respectively.
As data were not normally distributed, non-parametric statistical
tests were applied. The Kruskal-Wallis test was used to assess
differences in miRNAs concentrations. P-values were adjusted
using the Bonferroni correction.
A multivariate statistical analysis (Principal Component
Analysis—PCA, correlation matrix, no rotation) was used for
miR-320a, miR-342, miR-146a, miR-378a, miR-375, miR-423a,
miR-125b, miR-199 as an exploratory analysis to detect the
underlying relationships among miRNAs and to identify cases
clusters. Data assumptions were checked, KMO (Keiser Meyer
Olkin) and Bartlett’s test of sphericity were applied to test the
suitability of the data for structure detection. Factor scores were
calculated for dogs when the component’s Eigen value was greater
than one, to evaluate the distribution of the subjects according to
the considered variables and classed using the categories healthy
dogs and dogs with otitis.
To determine the diagnostic accuracy of targets differing
statistically between healthy and otitis affected dogs, receiver
operating characteristic (ROC) analysis was performed as
previously reported (45). The diagnostic values were calculated
for miRNAs that showed significant differential expression in the
buffalo blood.
RESULTS
Demographics and Characteristics of
Study Subjects
A total of 95 samples, 59 from healthy and 36 from ears affected
by otitis externa, were collected. The median age in the control
and otitis affected groups was 9 (ranging from 6 months to 15
years) and 8 (ranging from 1 to 14 years) years, respectively.
The male-to-female ratio was 11:17 in the healthy group and
11:10 in the otitis-affected group. A total of 19 different breeds
was included in the list, with an over-representation of Labrador
Retrievers (8) and German shepherds (5). The list of samples
including the diagnosis and cytological and bacteriological data
are listed in Supplementary Table 1.
Cytology and Bacteriology
Cytological findings and yeast and bacterial isolation results are
listed in Supplementary Table 1. Mites were not observed in any
of the cytological specimens. Cytology and culture evidenced
bacterial organisms (both coccoid and rod-shaped) and yeast
in clinically healthy and otitis affected ears independently of
the clinical presentation. As it could be assessed by cytology,
bacteria were higher in diseased ears. Yeast numbers did not
correlate with otitis. In three dogs with a clinical diagnosis of
otitis, neutrophils phagocytizing bacteria were observed in high
numbers and were consistent with the clinical finding of severe
otitis. Malassezia and bacterial organisms were isolated from
healthy and diseased ears and no association with otitis externa
was observed between number and type of yeast or bacteria.
RNA Extraction From Cerumen and
Determination of miRNome Profile
To characterize miRNA expression profiles of cerumen, a pilot
study small RNA-seq was performed on RNA extracted from the
cerumen samples of three healthy and three otitis-affected dogs.
After RNA extraction, small RNAs were selected according with
their size (≈146 bp band) and sequenced on the NextSeq500
sequencer (Illumina). Multiple reads per sample, varying from
349,000 to 11,000,000, were obtained. Counts table was used to
detect differentially expressed miRNAs via DESeq2 analysis (44).
Furthermore, the analysis revealed the expression of 102 Canis
familiaris (cfa) miRNAs, discarding lowly expressedmiRNAs (≤1
raw count across 6 samples).
MiRNAs Are Modulated in Cerumen of
Otitis-Affected Dogs
A cluster analysis based on the expression profiles of the
six sequenced samples was performed. The results allowed to
differentiate the samples in two clusters, namely cluster of
otitis-affected and cluster of healthy control group (Figure 1A).
To determine whether there were differences in the miRNAs
expression profile of healthy and otitis-affected samples, a
differential expression (DE) analysis applying using DESeq2
(44), with a threshold adjusted P < 0.1 and |log2FC| >1,
was performed. A difference in miRNA profiles was observed,
suggesting molecular changes due to otitis externa. Thirty-two
miRNAs were significantly altered in otitis-affected dogs, of
which 14 resulted upregulated (1.5- to 3.9- fold) and 18 down-
regulated (1.6- to 5.5- fold) (Figure 1B).
Validation of Differentially Expressed
miRNAs in Otitis-Affected and Healthy
Dogs
RT-qPCR validation was performed on the 6 sequenced samples
and on a separate independent set of 89 samples, collected from
56 from healthy and 33 from otitis-affected ears. To validate
the sequencing results, eight differentially expressed (DE)-
miRNAs were selected following their potential involvement in
regulating the immune system. Their relative abundance was
quantified using RT-qPCR. MiR-21-5p, miR-26a-5p, and miR-
27-3p were analyzed as endogenous controls for normalization.
Cel-miR-39, an artificial spike-in, was used as an internal
control. The results are presented in Figure 2. The selected
miRNA targets were detected in all samples. In accordance with
the sequencing data, RT-qPCR results demonstrated that the
levels of five miRNAs (miR-320a: P ≤ 0.0001, ratiohealthy/Otitis
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FIGURE 1 | Cerumen sequencing results. (A) Principal Component Analysis
(PCA) of six sequenced samples. Two-dimensional PCA was used to
determine whether otitis affected (blue point) could be distinguished from
healthy (pink points) subjects. (B) Identification of DE-miRNAs between otitis
affected and healthy dogs. Heat-map and table displaying the fold change and
Padj of DE-miRNAs.
= 17.5; miR-342: P ≤ 0.0001, ratiohealthy/Otitis = 15; miR-
146a: P≤ 0.0001, ratiohealthy/Otitis= 2.1; miR-378a: P = 0.0035,
ratiohealthy/Otitis = 2.9; miR-375: P ≤ 0.0001, ratiohealthy/Otitis
= 11) were significantly down-regulated in otitis-affected dogs.
Remarkably, the RT-qPCR validation for miR-125b (P ≤ 0.0001,
ratiohealthy/Otitis = 12.3) did not confirm the sequencing results,
presenting the evidence that this miRNA is down-regulated.
MiR-199 and miR-423a did not exhibit statistically significant
differences between otitis affected and healthy dogs.
The miR-320a, miR-342, miR-146a, miR-378a, miR-375,
miR-423a, miR-125b, and miR-199 abundance for the 95
samples were also analyzed together using Principal Component
Analysis (PCA, correlation matrix, no rotation), which is an
exploratory analysis tool used to explain the structure of a
set of variables through linear combinations. Good suitability
of data for PCA analysis was valued (KMO = 0.795 and
Bartlett’s test P≤ 0.001). The PCA revealed two main factors
with Eigenvectors greater than one, which together explains
75.9% of the variation between dogs. As shown in Figure 3A, the
first factor (PC1-Component 1; Eigenvalue = 3.927; Explained
variance = 49.092%) shows positive loadings for miR-320a,
miR-342, miR-375, miR-423a, and miR-125b. The second factor
(PC2-Component 2; Eigenvalue = 2.143; Explained variance
= 26.791%; Cumulative explained variance = 75.883%) shows
positive loadings for miR-146a, miR-378a, and miR-199. To test
whether there were any significant effects of the dog condition,
the PC miRNAs scores attributed to the samples on the first
two main components of the PCA (explaining 75.883% of
total variance) were analyzed through a Kruskal-Wallis test.
Based on the category healthy and otitis-affected, dogs did not
cluster homogeneously but were significantly (P ≤ 0.001) sorted
into two groups on PC1 (Figure 3B): one group with higher
variable values associated with healthy dogs and the second group
identified by a lower variability for otitis-affected dogs.
Assessment of the Diagnostic Value of
DE-miRNAs
To investigate the diagnostic value and the diagnostic potency of
DE-miRNAs in the cerumen, ROC curves and the area under
the curve (AUC) were calculated. The diagnostic performance
is reported in Table 1. The AUC was fair for miR-146a and
miR-378a, good for miR-342 and miR-375, and excellent for
miR-320a and miR-125b (Figure 4). Discriminant analysis was
carried out to investigate the potential for improving diagnostic
performance by analyzing multiple DE-miRNAs. The weighted
average relative quantification (RQ) values of the miRNAs
with an AUC>0.9 (miR-let-320a and miR-125b) and with
AUC>0.8 (miR-let-320a, miR-125b, miR-342, and miR-375)
were analyzed (Supplementary Figure 1). Median expression
levels including the RQ of 2 DE-miRNAs were 26 (range,
17.07–703.13) and 3.2 (range, 0.74–17.74) in healthy and otitis
affected dogs, respectively (Supplementary Figure 1A). Median
expression levels including the RQ of 4 DE-miRNAs were 13.3
(range, 3.31–367.7) and 1.69 (range, 0.24–9.1) in healthy and
otitis affected dogs, respectively (Supplementary Figure 1C).
The predicted probability of being discriminated as infected
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FIGURE 2 | Box plots of DE-miRNAs in otitis affected compared with healthy dogs. Significance was declared at *P < 0.05, and ***P < 0.001. Black lines inside the
boxes mark the medians. Whiskers indicate variability outside the upper and lower quartiles. (A) miR-320a, (B) miR-342, (C) miR-146a, (D) miR-378a, (E) miR-375,
(F) miR-125b, (G) miR-199, and (H) miR-432a.
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FIGURE 3 | Multivariate statistical analysis. (A) Projection for the loadings of the miRNAs considered for the First and Second Principal Component. (B) Score plot of
dogs in terms of clinical outcome.
TABLE 1 | Area under the curve (AUC), sensitivity, specificity, and accuracy for DE-miRNAs in the cerumen.
miRNA AUC 95% CI P-value Cut-off Sensitivity Specificity Accuracy
miR-320a 0.9202 0.8656–0.9748 <0.0001 0.9084 0.8636 0.9748 0.8254
miR-342 0.8758 0.79–0.9616 <0.0001 0.2308 0.7273 0.9268 0.8571
miR-146a 0.7749 0.6487–0.9012 <0.0001 1.7416 0.8636 0.7317 0.7778
miR-378a 0.7129 0.5732–0.8525 0.0028 1.5993 0.5909 0.8537 0.7619
miR-375 0.8703 0.7823–0.9583 <0.0001 0.1464 0.6364 1 0.8730
miR-125b 0.9834 0.9834–0.9834 <0.0001 0.4365 0.9545 0.9512 0.9524
Av_2 0.9607 0.9349–0.9865 <0.0001 10.28 0.8696 0.9286 0.9077
Av_4 0.9762 0.9762–0.9762 <0.0001 4.32 0.8696 0.9762 0.9385
Av_2, weighted average relative quantification of miR-320a and miR-125b; Av_4, weighted average relative quantification of miR-320a, miR-125b, miR-342, and miR-375.
from the logit model based on the two [logit = (19.5 ×
expression level of miR-320a) + (10.4 × expression level of
miR-125a)] or the four cerumen DE-miRNAs [logit = (19.5
× expression level of miR-320a) + (10.4 × expression level
of miR-125a) + (5.26 × expression level of miR-342) + (-
4.55 × expression level of miR-375)] was used to construct the
ROC curves (Supplementary Figures 1B,D). The results of ROC
curves analysis are reported in Table 1.
miRNA Localization, Target Prediction, and
Pathway Enrichment
To investigate the immune relevance, predicted targets of
DE-miRNAs were computationally retrieved from miRWalk
resources. The mRNA enrichment was performed using DAVID
bioinformatic tool. Since little information on alterations in
immune response contributing to the onset and progression
of otitis externa are available, an enrichment of mRNA targets
that encode for immunologically relevant genes was performed
comparing the target genes obtained from miRWalk with the
Gene List of ImmPort (46). The predicted mRNA targets of up-
regulatedmiRNAswere 270 [164 at 3′ untranslated region (UTR),
21 at 5
′
UTR, and 85 at codon sequence (CDS)], of which 21
were immune-related. The predicted mRNA targets of down-
regulated miRNAs were 133 (78 at 3′UTR, 10 at 5
′
UTR, and
45 at CDS), of which 15 were involved in immunity. The list
of immunologically relevant genes is reported in Table 2. KEGG
pathway analysis was performed on the enriched immune-related
targets of up- and down-regulated miRNAs using DAVID. The
top 10 significantly enriched KEGG pathways are reported in
Figure 5. The up-regulated miRNAs (Figure 5A) were identified
to be predominantly involved in the following pathways: HIF1
(Hypoxia Inducible Factor 1) and FoxO (Forkhead box O3)
signaling pathways. The down-regulated miRNAs (Figure 5B)
were revealed to be involved in the T cell receptor signaling
pathway, MAPK (Mitogen-Activated Protein Kinase) signaling
pathway, Focal adhesion, and RAP1 (Ras-proximate-1) signaling
pathway. Aiming for further understanding the associated
functions of the DE-miRNAs, Gene Ontology (GO) analysis
was performed. GO enrichment analysis included the categories
molecular function (MF), cellular component (CC), biological
process (BP) (Figure 6). For down-regulated miRNAs, most
MF items mainly included genes involved in the regulation
of MAPK activity, growth factor activity, and heparin-binding;
the enriched CC converged on genes associated with the
nucleoplasm and extracellular exosomes, while BP on ROS
(Reactive oxygen species) metabolic species, signal transduction
in response to DNA damage, and VEGF (Vascular-Endothelial
Growth Factor) receptor signaling pathway. For up-regulated
miRNAs, MF items focused on steroid hormone receptor
activity and insulin receptor substrate binding; CC converged
on receptor complex, phosphatidylinositol 3-kinase complex and
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FIGURE 4 | Receiver-operator characteristic (ROC) curve analysis of DE-miRNAs in the cerumen. AUC, area under the curve; CI, confidence interval. (A) miR-320a,
(B) miR-342, (C) miR-146a, (D) miR-378a, (E) miR-375, and (F) miR-125b.
integral component of plasma membrane, and BP on positive
regulation of transcription from RNA polymerase II promoter,
steroid hormone-mediated signaling pathway, and positive
regulation of cell migration. To identify which type of cells in
cerumen express DE-miRNAs, the atlas of miRNA expression
(FANTOM5) in immune cells and keratinocytes was explored.
The radar chart reported in Figure 7A presents the contribution
of cells to the production of up- and down-regulated miRNAs.
In detail, down-regulated miRNAs are produced mainly by
keratinocytes, monocytes, dendritic cells, and T cells, while up-
regulated miRNAs by B cells and mast cells. The miRNA–mRNA
networks determined using miRNet database are presented in
Figures 7B,C.
DISCUSSION
The findings of this study provided for the first-time evidence
that (a) miRNAs can be efficiently extracted, sequenced, and
quantified by RT-qPCR from canine cerumen and (b) cerumen
microRNAs quantities change during otitis externa. In the first
part of the investigation, a pilot sequencing study was performed
to profile the miRNome of cerumen, showing that otitis externa
TABLE 2 | Immune-related target genes of differentially expressed miRNAs.
Immune-related genes targeted by
up-regulated miRNAs
Immune-related genes targeted
by down-regulated miRNAs
FASLG, IGF1R, TGFBR3, SOCS1, CRLF3,
NR2C2, RORA, NR4A3, CREB1, STAT3,
VDR, INSR, ACVR2A, KDR, NR3C1,
PTGER4, EDN1, PIK3R1, NR6A1,
PIK3CA, PPP3R1
BDNF, THBS1, CDC42, VEGFA,
IFNG, PDGFRB, MAPK14, PAK4,
CMTM4, GRB2, LRP1, NFATC3,
NFAT5, SP1, MAPK1
changed the expression of 32 miRNAs, of which 14 were more
abundant and 18 were less abundant compared to healthy dogs.
In the second step, 8 differentially expressed miRNAs were
validated on a larger cohort using a RT-qPCR approach. It
was found that miR-320a, miR-342, miR-146a, miR-378a, miR-
375, and miR-125b were down-regulated in cerumen from otitis
affected dogs. The results are supported by PCA analysis, of
which the first principal component accounts for as much of the
variability in the data as possible. miRNAs on this component
are the most important in explaining the differences between
healthy and otitis-affected dogs. Moreover, heat map, hierarchical
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FIGURE 5 | Pathway enrichment analysis for genes regulated by (A) up- and (B) down-regulated miRNAs. Genes regulated by DE-miRNAs were retrieved and
enriched in KEGG using DAVID. The P-value was negative 10-base log transformed. The top 10 enriched KEGG pathways are reported.
clustering, and PCA revealed that dogs with otitis showed
increased variability in miRNA levels compared to healthy ones.
Given the functions of the target genes regulated by DE-
miRNAs, the current findings demonstrated that miRNAs
contained in cerumen might interact with several pathways
involved in the host innate immunity, including modulation
the inflammatory reaction, the regulation of M1/M2 monocyte
lineage polarization, the resolution of inflammation, and
reparation of damaged tissues.
All DE-miRNAs are involved in pathways that regulate
the inflammatory reaction. Therefore, their down-regulation
provides cerumen with a potential pro-inflammatory activity,
following a mechanism different for each DE-miRNAs.
For example, the downregulation of miR-320a induced
the overexpression of pro-inflammatory cytokines through
promoting COX-2 (Cyclooxygenase-2) expression by targeting
MAPK-1 (47). In macrophages, decreasing miR-125b-5p has
a dual, apparently opposite, effect of increasing secretion
of the pro-inflammatory chemokine MCP-1 (Monocyte
chemoattractant protein-1) (48) and upregulating B7-H4 in
macrophages, which induces an anti-inflammatory effect
(49). Decreasing miR-378a through targeting CD47-SIRPα
(Signal Regulatory Protein Alpha) inhibits phagocytosis in
macrophages, and promotes the secretion of TNFα (Tumor
Necrosis Factor-alpha) and IL-6 (Interleukin-6) (50). MiR-375
regulates the expression of pro-inflammatory cytokines such
as IL1-β, TNFα, and IL-6: therefore, miR-375 decrease also
reduces cytokine expression, as shown in a myocardial infarction
model (51). Finally, miR-146 is involved in the regulation
of inflammation via negative feedback of toll-like receptor
signaling (TLR) (52), as already described in otitis media
in humans (24): consequently, down-regulation of miR-146
induces a pro-inflammatory effect. Moreover, miR-125b and
miR-146, which are also reduced after TLR activation, can
promote tolerance to endotoxin (53). We found that all these
miRNAs are less abundant in cerumen of dogs affected by
otitis, confirming what has been already reported in other
diseases such as for miR-342 (54) and miR-375 in sepsis,
or during C5a (complement component C5a) activation for
miR-320a (55).
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FIGURE 6 | Target prediction. GO annotation of genes regulated by (A) up- and (B) down-regulated miRNAs. The target genes were annotated by DAVID at three
levels: molecular function, cellular component, and biological process. The top 10 significantly enriched items are shown.
FIGURE 7 | Localization of DE-miRNAs and network analysis of miRNAs-immune-related target genes in the cerumen. (A) FANTOM5 miRNAS atlas was analyzed for
the expression of DE-miRNAs in immune cells and keratinocytes. Expression (counts per million) was plotted for these miRNAs in the radar graph; (B) network of
over-expressed miRNAs constructed using miRNet; (C) network of down-regulated miRNAs constructed using miRNet. The blue squares represent miRNAs, the red
dots mRNA.
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All DE-miRNAs are also involved in the modulation of
monocyte/macrophage polarization. Specifically, miR-125b,
miR-378, miR-375, and miR-372 are involved in polarization
to M1 lineage whereas miR-320a and miR-146a are involved
in polarization toward M2 lineage. MiR-320a, in particular,
was found in epithelial-derived microvesicles, and could
activate macrophage pro-inflammatory effects (56). The
effect of miR-320a may be even more complex since a more
recent study demonstrated that miR-320a promotes the
polarization toward immunosuppressive M2 macrophages
meanwhile inducing polarization toward M1 lineage (57).
Moreover, the effects of miR-375 require a more in-depth
investigation since the inhibition of miR-375 represses M1
macrophage polarization and promotes M2 macrophage
polarization, targeting PDK-1 (Pyruvate Dehydrogenase Kinase
1) (51).
Following their inflammatory functions, classical M1
macrophages feature higher capabilities of phagocytosis and,
more in general, a pro-inflammatory phenotype. On the contrary,
non-classical M2 monocytes share a lower pro-inflammatory
activity, although their precise physiological roles remain still
poorly defined (58). Given the background that miRNAs play
pivotal roles in macrophage activation and polarization (59),
the finding that miRNAs involved in monocyte/macrophage
polarization were detected in cerumen was not surprising
and suggests that during inflammatory responses, monocytes
are attracted to cerumen, and become activated on site and
modulated by miRNAs.
The DE-miRNAs are involved in a third mechanism
represented by the regulation of repair pathways after
inflammation. For example, miR-320a is involved in intestinal
mucosal reconstitution and repair after inflammation (60), and
miR-125b inhibits proliferation and promotes differentiation
of keratinocytes in the skin (61). Therefore, the capability of
cerumen to down-regulate miR-320a andmiR-125bmay result in
keratinocyte proliferation, which in turn may accelerate wound
healing and homeostasis restitution.
Although neutrophils were observed in high numbers only
in three dogs, cytological findings associated always with otitis
paralleling the observations of Angus (62). According to our
results, cytology should be considered a specific diagnostic
technique assisting in the diagnosis of otitis in dogs although
bearing lower sensitivity. Isolation of yeasts and bacteria species
did not correspond to a specific condition; however, increased
numbers of bacteria were evidenced in cases of otitis as
previously reported (62). These findings suggested that isolation
of organisms should be assessed in the context of clinical
presentation and cytological findings as an adjunctive tool
to support diagnostic and therapeutic protocols. Noteworthy,
cytology and microbiology did not always result in sensitive
techniques to distinguish healthy vs. diseased ears. On the
contrary, ROC analysis highlighted that two miRNAs, namely
miR-125b and miR-320a, can discriminate otitis-affected from
healthy dogs with high sensitivity (>86%) and specificity
(>97%), confirming that these miRNAs may be excellent
candidate biomarkers. These findings are more relevant if
considered that differentiation among diseased and normal ears
occurred independently from the presence of elevated numbers
of neutrophils thus independently of morphological features
of inflammation.
Currently, one of the main issues in human as well as
in veterinary medicine is the overuse of antibiotics, which
promotes the selection of resistant commensal flora. Careful use
of antibiotics for treatment of cutaneous infections, including
otitis externa in dogs, is recommended (63). We believe that
molecular biomarkers, such as the miRNAs identified in this
work, may assist the clinical monitoring of drug effectiveness
during otitis externa treatment. To support this hypothesis,
further studies will be performed on cerumen collected from
dogs affected by otitis and treated with antibiotics. Moreover,
as allergic dermatitis is the most frequently recognized primary
cause of canine otitis externa (64), further studies evaluating
the change of biomarkers expression in allergic dogs, without
symptomatic otitis externa, compared to healthy subjects could
provide the clinician with a valuable screening method to
monitor the ear canal inflammatory status. This could, in
turn, support the proactive use of targeted anti-inflammatory
treatments aimed to prevent the development of secondary
infections decreasing further the use of antibiotics and the risk
of bacterial resistance.
In conclusion, to the best of the authors’ knowledge, this is the
first report demonstrating the presence of miRNAs in cerumen
and their changes in dogs with acute otitis externa. These findings
provided insights on the role of miRNAs in modulating immune
defenses in cerumen, a biological fluid whose importance has
been almost completely neglected so far, meanwhile highlighting
the potential role of cerumen as a source of biomarkers. In this
work, the finding of miRNAs differential expression is relevant
for a better understanding of the pathogenic mechanism leading
to otitis and tampering of external ear damage and provides a
novel technique able to discriminate healthy vs. otitis-affected
ears representing a more specific and sensitive diagnostic tool
compared to cytology and microbiology. Thus, the abnormal
expression of miRNAsmay lead to an early diagnosis of otitis and
timely treatment.
Further studies are necessary to confirm their diagnostic
values by increasing the number of clinical samples, associating
their abundance with specific pathogens and antibiotic treatment,
and to investigate the direct interaction between these miRNAs
and their target genes.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation, to any
qualified researcher.
ETHICS STATEMENT
All applicable international, national, and/or institutional
guidelines for the care and use of animals were followed.
Samples were collected during routine health checks or
clinical evaluation of affected dogs, under informed consent of
Frontiers in Immunology | www.frontiersin.org 11 May 2020 | Volume 11 | Article 914
Lecchi et al. Cerumen miRNA of Otitis Affected Dogs
the owners and out of the scope of Directive 2010/63/EU
(art. 1.5.f practices not likely to cause pain, suffering,
distress or lasting harm equivalent to, or higher than,
that caused by the introduction of a needle in accordance
with good veterinary practice). This study design was
approved by the Italian Ministry of Health, project n. IZS
ME 13_15 RC.
AUTHOR CONTRIBUTIONS
CL and FC conceived and designed the experiments and
provided the original idea of the study. PR, RP, SL, and ED’U
enrolled patients and performed the clinical diagnosis. MC
and GGr carried out the cytology and microbiological analysis,
respectively. MA performed the sequencing experiment. RC,
MM, and CL performed bioinformatics and statistical analysis.
CL and VZ performed the RT-qPCR experiments. FC, GGa, and
GB funded the project. CL wrote the first draft of the manuscript.
All authors read and approved the final draft of the manuscript.
FUNDING
This research was provided by Italian Ministry of Health—
Ricerca Corrente 2015 -IZS ME 13/15 RC. This funding for RT-
qPCR was provided by Fondo per il Finanziamento delle Attività
Base di Ricerca—FFABR-Lecchi.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fimmu.
2020.00914/full#supplementary-material
REFERENCES
1. Kim E, Choe C, Yoo JG, Oh S-I, Jung Y, Cho A, et al. Major medical
causes by breed and life stage for dogs presented at veterinary clinics in
the republic of Korea: a survey of electronic medical records. PeerJ. (2018)
6:e5161. doi: 10.7717/peerj.5161
2. O’Neill DG, Baral L, Church DB, Brodbelt DC, Packer RMA. Demography
and disorders of the French bulldog population under primary
veterinary care in the UK in 2013. Canine Genet Epidemiol. (2018)
5:3. doi: 10.1186/s40575-018-0057-9
3. O’Neill DG, Seah WY, Church DB, Brodbelt DC. Rottweilers under primary
veterinary care in the UK: demography, mortality and disorders. Canine Genet
Epidemiol. (2017) 4:13. doi: 10.1186/s40575-017-0051-7
4. Perry LR, MacLennan B, Korven R, Rawlings TA. Epidemiological study of
dogs with otitis externa in Cape Breton, Nova Scotia. Can Vet J La Rev Vet
Can. (2017) 58:168–74.
5. Bloom P. A practical approach to diagnosing and managing ear disease in
dogs. Compend Contin Educ Vet. (2009) 31:E1–5.
6. Rosser EJ. Causes of otitis externa. Vet Clin North Am Small Anim Pract.
(2004) 34:459–68. doi: 10.1016/j.cvsm.2003.10.006
7. Paterson S. Topical ear treatment - options, indications and
limitations of current therapy. J Small Anim Pract. (2016)
57:668–78. doi: 10.1111/jsap.12583
8. Sparber F, LeibundGut-Landmann S. Host responses to
Malassezia spp. in the Mammalian Skin. Front Immunol. (2017)
8:1614. doi: 10.3389/fimmu.2017.01614
9. Morris DO, Clayton DJ, Drobatz KJ, Felsburg PJ. Response to Malassezia
pachydermatis by peripheral blood mononuclear cells from clinically normal
and atopic dogs. Am J Vet Res. (2002) 63:358-62. doi: 10.2460/ajvr.2002.63.358
10. Layne EA, DeBoer DJ. Serum Malassezia-specific IgE in dogs with recurrent
Malassezia otitis externa without concurrent skin disease. Vet Immunol
Immunopathol. (2016) 176:1–4. doi: 10.1016/j.vetimm.2016.05.008
11. Chai TJ, Chai TC. Bactericidal activity of cerumen. Antimicrob Agents
Chemother. (1980) 18:638–41. doi: 10.1128/AAC.18.4.638
12. Feig MA, Hammer E, Völker U, Jehmlich N. In-depth proteomic analysis
of the human cerumen-A potential novel diagnostically relevant biofluid. J
Proteomics. (2013) 83:119–29. doi: 10.1016/j.jprot.2013.03.004
13. Yoon YJ, Park JW, Lee EJ. Presence of hBD-1 and hBD-2 in human
cerumen and external auditory canal skin. Acta Otolaryngol. (2008) 128:871–
5. doi: 10.1080/00016480701785020
14. Shokry E, Filho NRA. Insights into cerumen and application in
diagnostics: past, present and future prospective. Biochem Medica. (2017)
27:030503. doi: 10.11613/BM.2017.030503
15. Griffin JS, Scott DW, Erb HN. Malassezia otitis externa in the dog: the
effect of heat-fixing otic exudate for cytological analysis. J Vet Med A
Physiol Pathol Clin Med. (2007) 54:424–7. doi: 10.1111/j.1439-0442.2007.0
0938.x
16. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell.
(2009) 136:215–33. doi: 10.1016/j.cell.2009.01.002
17. Schulte LN, Bertrams W, Stielow C, Schmeck B. ncRNAs in
inflammatory and infectious diseases. Methods Mol Biol. (2019)
1912:3–32. doi: 10.1007/978-1-4939-8982-9_1
18. Markopoulos GS, Roupakia E, Tokamani M, Chavdoula E, Hatziapostolou M,
Polytarchou C, et al. A step-by-step microRNA guide to cancer development
and metastasis. Cell Oncol. (2017) 40:303–39. doi: 10.1007/s13402-017-0341-9
19. Dong H, Gao Q, Peng X, Sun Y, Han T, Zhao B, et al. Circulating microRNAs
as potential biomarkers for veterinary infectious diseases. Front Vet Sci. (2017)
4:186. doi: 10.3389/fvets.2017.00186
20. Lecchi C, Dalla Costa E, Lebelt D, Ferrante V, Canali E, Ceciliani F,
et al. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential
biomarkers to monitor acute pain associated with laminitis in horses. Animal.
(2018) 12:366–75. doi: 10.1017/S1751731117001525
21. Lecchi C, Marques AT, Redegalli M, Meani S, Vinco LJ, Bronzo V,
et al. Circulating extracellular miR-22, miR-155, and miR-365 as candidate
biomarkers to assess transport-related stress in turkeys. Animal. (2016)
10:1213–7. doi: 10.1017/S1751731115003043
22. Ruksha TG, Komina A V, Palkina N V. MicroRNA in skin diseases. Eur J
Dermatol. (2017) 27:343–52. doi: 10.1684/ejd.2017.3024
23. Val S, Jeong S, Poley M, Krueger A, Nino G, Brown K, et al. Purification
and characterization of microRNAs within middle ear fluid exosomes:
implication in otitis media pathophysiology. Pediatr Res. (2017) 81:911–
8. doi: 10.1038/pr.2017.25
24. Samuels TL, Yan J, Khampang P, MacKinnon A, Hong W, Johnston
N, et al. Association of microRNA 146 with middle ear hyperplasia
in pediatric otitis media. Int J Pediatr Otorhinolaryngol. (2016) 88:104–
8. doi: 10.1016/j.ijporl.2016.06.056
25. Ginel PJ, Lucena R, Rodriguez JC, Ortega J. A semiquantitative
cytological evaluation of normal and pathological samples from
the external ear canal of dogs and cats. Vet Dermatol. (2002)
13:151–6. doi: 10.1046/j.1365-3164.2002.00288.x
26. De Martino L, Nocera FP, Mallardo K, Nizza S, Masturzo E, Fiorito
F, et al. An update on microbiological causes of canine otitis externa
in Campania region, Italy. Asian Pac J Trop Biomed. (2016) 6:384–
9. doi: 10.1016/j.apjtb.2015.11.012
27. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M,
et al. The MIQE guidelines: minimum information for publication
Frontiers in Immunology | www.frontiersin.org 12 May 2020 | Volume 11 | Article 914
Lecchi et al. Cerumen miRNA of Otitis Affected Dogs
of quantitative real-time PCR experiments. Clin Chem. (2009) 55:611–
22. doi: 10.1373/clinchem.2008.112797
28. Pardini B, Cordero F, Naccarati A, Viberti C, Birolo G, Oderda
M, et al. microRNA profiles in urine by next-generation
sequencing can stratify bladder cancer subtypes. Oncotarget. (2018)
9:20658–69. doi: 10.18632/oncotarget.25057
29. Bovine Genome Sequencing Analysis Consortium, Elsik CG, Tellam RL,
Worley KC, Gibbs RA, Muzny DM, et al. The genome sequence of taurine
cattle: a window to ruminant biology and evolution. Science. (2009) 324:522–
8. doi: 10.1126/science.1169588
30. Cordero F, Beccuti M, Arigoni M, Donatelli S, Calogero RA. Optimizing
a massive parallel sequencing workflow for quantitative miRNA expression
analysis. PLoS ONE. (2012) 7:e31630. doi: 10.1371/journal.pone.0031630
31. Beccuti M, Cordero F, Arigoni M, Panero R, Amparore EG,
Donatelli S, et al. SeqBox: RNAseq/ChIPseq reproducible
analysis on a consumer game computer. Bioinformatics. (2018)
34:871–2. doi: 10.1093/bioinformatics/btx674
32. Martin M. Cutadapt removes adapter sequences from high-throughput
sequencing reads. EMBnet.journal. (2011) 17:10. doi: 10.14806/ej.17.1.200
33. Rumble SM, Lacroute P, Dalca A V, Fiume M, Sidow A, Brudno M. SHRiMP:
accurate mapping of short color-space reads. PLoS Comput Biol. (2009)
5:e1000386. doi: 10.1371/journal.pcbi.1000386
34. Eisenberg E, Levanon EY. Human housekeeping genes, revisited. Trends
Genet. (2013) 29:569–74. doi: 10.1016/j.tig.2013.05.010
35. Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: An online
resource for prediction of microRNA binding sites. PLoS ONE. (2018)
13:e0206239. doi: 10.1371/journal.pone.0206239
36. Wong N, Wang X. miRDB: an online resource for microRNA target
prediction and functional annotations. Nucleic Acids Res. (2015) 43:D146–
52. doi: 10.1093/nar/gku1104
37. Hsu S-D, Lin F-M, Wu W-Y, Liang C, Huang W-C, Chan W-L, et al.
miRTarBase: a database curates experimentally validated microRNA-target
interactions. Nucleic Acids Res. (2011) 39:D163–9. doi: 10.1093/nar/gkq1107
38. Agarwal V, Bell GW, Nam J-W, Bartel DP. Predicting effective
microRNA target sites in mammalian mRNAs. Elife. (2015)
4:e5005. doi: 10.7554/eLife.05005
39. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis
of large gene lists using DAVID bioinformatics resources. Nat Protoc. (2009)
4:44–57. doi: 10.1038/nprot.2008.211
40. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools:
paths toward the comprehensive functional analysis of large gene lists. Nucleic
Acids Res. (2009) 37:1–13. doi: 10.1093/nar/gkn923
41. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration
and interpretation of large-scale molecular data sets. Nucleic Acids Res. (2012)
40:D109–14. doi: 10.1093/nar/gkr988
42. Fan Y, Xia J. miRNet-functional analysis and visual exploration of miRNA-
target interactions in a network context. In: von Stechow L, Santos
Delgado A, editors. Computational Cell Biology. Methods in Molecular
Biology. Vol. 1819. New York, NY: Humana Press (2018). p. 215–
33. doi: 10.1007/978-1-4939-8618-7_10
43. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The
sva package for removing batch effects and other unwanted
variation in high-throughput experiments. Bioinformatics. (2012)
28:882–3. doi: 10.1093/bioinformatics/bts034
44. Love MI, Huber W, Anders S. Moderated estimation of fold change
and dispersion for RNA-seq data with DESeq2. Genome Biol. (2014)
15:550. doi: 10.1186/s13059-014-0550-8
45. Lecchi C, Catozzi C, Zamarian V, Poggi G, Borriello G, Martucciello A,
et al. Characterization of circulating miRNa signature in water buffaloes
(Bubalus bubalis) during Brucella abortus infection and evaluation as potential
biomarkers for non-invasive diagnosis in vaginal fluid. Sci Rep. (2019)
9:1945. doi: 10.1038/s41598-018-38365-x
46. Bhattacharya S, Dunn P, Thomas CG, Smith B, Schaefer H, Chen
J, et al. ImmPort, toward repurposing of open access immunological
assay data for translational and clinical research. Sci Data. (2018)
5:180015. doi: 10.1038/sdata.2018.15
47. Cheng Z, Qiu S, Jiang L, Zhang A, Bao W, Liu P, et al. MiR-
320a is downregulated in patients with myasthenia gravis and modulates
inflammatory cytokines production by targeting mitogen-activated protein
kinase 1. J Clin Immunol. (2013) 33:567–76. doi: 10.1007/s10875-012-9834-5
48. Lu J-B, Yao X-X, Xiu J-C, Hu Y-W. MicroRNA-125b-5p attenuates
lipopolysaccharide-induced monocyte chemoattractant protein-1 production
by targeting inhibiting LACTB in THP-1macrophages. Arch Biochem Biophys.
(2016) 590:64–71. doi: 10.1016/j.abb.2015.11.007
49. Diao W, Lu L, Li S, Chen J, Zen K, Li L. MicroRNA-125b-5p modulates the
inflammatory state of macrophages via targeting B7-H4. Biochem Biophys Res
Commun. (2017) 491:912–8. doi: 10.1016/j.bbrc.2017.07.135
50. ChenW, Li X,Wang J, Song N, Zhu A, Jia L. miR-378amodulates macrophage
phagocytosis and differentiation through targeting CD47-SIRPα axis in
atherosclerosis. Scand J Immunol. (2019) 90:e12766. doi: 10.1111/sji.12766
51. Garikipati VNS, Verma SK, Jolardarashi D, Cheng Z, Ibetti J, Cimini M,
et al. Therapeutic inhibition of miR-375 attenuates post-myocardial infarction
inflammatory response and left ventricular dysfunction via PDK-1-AKT
signalling axis. Cardiovasc Res. (2017) 113:938–949. doi: 10.1093/cvr/cvx052
52. Lee H-M, Kim TS, Jo E-K. MiR-146 and miR-125 in the
regulation of innate immunity and inflammation. BMB Rep. (2016)
49:311–8. doi: 10.5483/BMBRep.2016.49.6.056
53. Vergadi E, Vaporidi K, Tsatsanis C. Regulation of endotoxin tolerance and
compensatory anti-inflammatory response syndrome by non-coding RNAs.
Front Immunol. (2018) 9:2705. doi: 10.3389/fimmu.2018.02705
54. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Müller M. In vivo profile of the
human leukocyte microRNA response to endotoxemia. Biochem Biophys Res
Commun. (2009) 380:437–41. doi: 10.1016/j.bbrc.2008.12.190
55. Eadon MT, Jacob A, Cunningham PN, Quigg RJ, Garcia JGN, Alexander
JJ. Transcriptional profiling reveals that C5a alters microRNA in brain
endothelial cells. Immunology. (2014) 143:363–73. doi: 10.1111/imm.12314
56. Lee H, Zhang D, Zhu Z, Dela Cruz CS, Jin Y. Epithelial
cell-derived microvesicles activate macrophages and promote
inflammation via microvesicle-containing microRNAs. Sci Rep. (2016)
6:35250. doi: 10.1038/srep35250
57. Essandoh K, Li Y, Huo J, FanG-C.MiRNA-Mediatedmacrophage polarization
and its potential role in the regulation of inflammatory response. Shock. (2016)
46:122–31. doi: 10.1097/SHK.0000000000000604
58. Hussen J, Schuberth H-J. Heterogeneity of bovine peripheral blood
monocytes. Front Immunol. (2017) 8:1875. doi: 10.3389/fimmu.2017.01875
59. Curtale G, Rubino M, Locati M. MicroRNas as molecular
switches in macrophage activation. Front Immunol. (2019)
10:799. doi: 10.3389/fimmu.2019.00799
60. Lopetuso LR, De Salvo C, Pastorelli L, Rana N, Senkfor HN, Petito V,
et al. IL-33 promotes recovery from acute colitis by inducing miR-320 to
stimulate epithelial restitution and repair. Proc Natl Acad Sci USA. (2018)
115:E9362–70. doi: 10.1073/pnas.1803613115
61. Zheng Y, Cai B, Li X, Li D, Yin G. MiR-125b-5p and miR-181b-5p inhibit
keratinocyte proliferation in skin by targeting Akt3. Eur J Pharmacol. (2019)
862:172659. doi: 10.1016/j.ejphar.2019.172659
62. Angus JC. Otic cytology in health and disease. Vet Clin North Am Small Anim
Pract. (2004) 34:411–24. doi: 10.1016/j.cvsm.2003.10.005
63. Bourély C, Cazeau G, Jarrige N, Leblond A, Madec JY, Haenni M, et al.
Antimicrobial resistance patterns of bacteria isolated from dogs with otitis.
Epidemiol Infect. (2019) 147:e121. doi: 10.1017/S0950268818003278
64. Zur G, Lifshitz B, Bdolah-Abram T. The association between the signalment,
common causes of canine otitis externa and pathogens. J Small Anim Pract.
(2011) 52:254–8. doi: 10.1111/j.1748-5827.2011.01058.x
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Lecchi, Zamarian, Borriello, Galiero, Grilli, Caniatti, D’Urso,
Roccabianca, Perego, Minero, Legnani, Calogero, Arigoni and Ceciliani. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Immunology | www.frontiersin.org 13 May 2020 | Volume 11 | Article 914
